Quinupristin/dalfopristin: A novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive pathogens

Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides

Fred C. Tenover, Christine D. Steward, Gary A. Hancock · Journal of Clinical Microbiology · 1998 · 377 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +13

Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides

Fred C. Tenover, Michael V. Lancaster, Bertha C. Hill et al. · Journal of Clinical Microbiology · 1998 · 361 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +13

Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

Ronald Lee Nichols, Donald R. Graham, Steven L. Barriere et al. · Journal of Antimicrobial Chemotherapy · 1999 · 178 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada

Ronald N. Jones, Charles H. Ballow, Douglas J. Biedenbach et al. · Diagnostic Microbiology and Infectious Disease · 1998 · 160 citations

Life Sciences, Infectious Diseases, Microbiology +14

Mechanism of Action of Streptogramins and Macrolides

Pascal Vannuffel, C. Cocito · Drugs · 1996 · 139 citations

Medicine, Pharmacology, Pharmacodynamics +2